HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsin-Han Chang Selected Research

fatty acid-binding protein 6

2/2022Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers.
10/2021Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsin-Han Chang Research Topics

Disease

10Neoplasms (Cancer)
06/2022 - 01/2018
4Urinary Bladder Neoplasms (Bladder Cancer)
05/2022 - 01/2020
4Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2018
2Adenocarcinoma of Lung
06/2022 - 09/2021
2Malignant Pleural Effusion
09/2021 - 02/2021
2Carcinoma (Carcinomatosis)
07/2021 - 01/2020
2Glioma (Gliomas)
09/2020 - 01/2018
1Lung Neoplasms (Lung Cancer)
06/2022
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2022
1Wounds and Injuries (Trauma)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
10/2021
1Breast Neoplasms (Breast Cancer)
02/2021
1Disease Progression
02/2021
1Triple Negative Breast Neoplasms
02/2021
1Carcinogenesis
09/2020
1Cardiovascular Diseases (Cardiovascular Disease)
03/2020
1Chronic Renal Insufficiency
05/2019
1Muscular Atrophy (Muscle Atrophy)
05/2019
1Atrophy
05/2019
1Sarcopenia
05/2019

Drug/Important Bio-Agent (IBA)

4Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 01/2018
3Bile Acids and Salts (Bile Acids)IBA
06/2022 - 10/2021
3Messenger RNA (mRNA)IBA
05/2022 - 05/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 11/2020
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
06/2022 - 05/2022
2Proteins (Proteins, Gene)FDA Link
05/2022 - 05/2019
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2022 - 05/2019
2fatty acid-binding protein 6IBA
02/2022 - 10/2021
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2021 - 11/2020
2Pharmaceutical PreparationsIBA
07/2021 - 01/2020
2IndicanIBA
03/2020 - 05/2019
2Uremic ToxinsIBA
03/2020 - 05/2019
2Myosin Light Chains (Myosin Essential Light Chain)IBA
05/2019 - 01/2018
1LipidsIBA
06/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2022
1CarcinogensIBA
06/2022
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
05/2022
1Cisplatin (Platino)FDA LinkGeneric
02/2022
1Saline SolutionIBA
01/2022
1Carrier Proteins (Binding Protein)IBA
10/2021
1Bevacizumab (Avastin)FDA Link
09/2021
1Gefitinib (Iressa)FDA Link
09/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2021
1pregna-4,17-diene-3,16-dione (guggulsterone)IBA
07/2021
1Phytoestrogens (Phytoestrogen)IBA
07/2021
1Caspase 3 (Caspase-3)IBA
07/2021
1Hormones (Hormone)IBA
02/2021
1Estrogen ReceptorsIBA
02/2021
1Small Interfering RNA (siRNA)IBA
11/2020
1NF-kappa B (NF-kB)IBA
09/2020
1magnololIBA
01/2020
1honokiolIBA
01/2020
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2018
1TRPC3 cation channelIBA
01/2018

Therapy/Procedure

5Therapeutics
09/2021 - 01/2018
1Aftercare (After-Treatment)
05/2022
1Drug Therapy (Chemotherapy)
01/2022
1Radiotherapy
01/2022